Posts Tagged ‘pharmaceutical’
Government expects $140M in savings this year with refugee health care co-pay
Friday, May 8th, 2026
Claimants will cover a $4 fee for prescriptions and cover 30 per cent of the cost for services not typically covered by the public health care system… co-pays are expected to cover about $140 million in 2026-27, including $92.9 million in savings from dental care alone… Another $10.6 million is expected to be saved on prescriptions, $6.2 million from vision care, and $16.7 million from counselling… Routine doctor visits, emergency medicine, vaccines, hospital stays and lab work continue to be fully covered by the program.
Tags: budget, Health, immigration, jurisdiction, pharmaceutical
Posted in Inclusion Policy Context | 3 Comments »
Ford government to end funding for supervised consumption sites, advocates say — including two in Toronto
Thursday, March 19th, 2026
… the province is providing the sites 90 days’ notice “in order to support an orderly transition for clients so they can access other community health services… The sites are being asked to provide a plan for how they will transition clients to other community health services and realign their services to promote rehabilitation.
Tags: ideology, jurisdiction, mental Health, pharmaceutical
Posted in Health Delivery System | No Comments »
Why Ontario’s measles outbreak highlights our need for a vaccine registry
Thursday, February 12th, 2026
Ontario’s measles outbreak has laid bare how vulnerable we are without the essential tools needed to know who is protected and who is not…The solution is clear — and it’s not a crumpled yellow vaccine card. Ontarians need… a comprehensive immunization registry… a secure, province-wide system that’s accessible from family doctors’ offices to ERs across the province.
Tags: Health, jurisdiction, participation, pharmaceutical, standard of living, youth
Posted in Health Policy Context | No Comments »
Feds revive bill to build digitally connected health data systems for patients, providers
Thursday, February 5th, 2026
Canada’s health data system is “fragmented and siloed” and incomplete health records can compromise patient care and safety… If passed, the legislation would establish standards that companies developing electronic medical records must follow, allowing data to be shareable between health-care providers and across provinces and territories… “Canada’s diversity and single-payer model has created one of the most valuable health data sets on Earth,”
Tags: Health, jurisdiction, mental Health, pharmaceutical
Posted in Health Policy Context | No Comments »
Why drug approval in Canada should not rely on foreign regulators
Friday, January 30th, 2026
So far, there is no evidence to back up the claim that using decisions made by foreign drug regulators will lead to faster access to newer and better drugs. Before Canada proceeds down this pathway, Health Canada needs to show that it will improve public health.
Tags: Health, jurisdiction, pharmaceutical
Posted in Health Policy Context | No Comments »
4 things you need to know about health care in the federal budget
Monday, December 8th, 2025
Nearly $400 million in cuts to health… No plan to expand pharmacare… $5 billion for buildings – but no plan for health care workers… Cuts to refugee health care… “The affordability crisis is worsening, and Canadians need to know health care will be there when they need it most.
Tags: budget, Health, immigration, jurisdiction, pharmaceutical
Posted in Health Debates | No Comments »
Update the Canada Health Act
Monday, November 10th, 2025
After four decades, Canadians have a clearer sense of the system’s strengths and weaknesses. And the pandemic underscored both the value of universal health care and the urgent need for modernization… many changes could be achieved through more efficient organization, not just more spending. Nurse practitioners and physician assistants can often provide high-quality primary care less expensively than physicians, while expanded roles for pharmacists or midwives could also achieve savings and relieve some of the workload falling solely to family doctors.
Tags: economy, featured, Health, jurisdiction, pharmaceutical, standard of living
Posted in Health Debates | No Comments »
If a mine is a nation-building project, why not universal pharmacare? Inside the big push to get Mark Carney behind it
Monday, October 27th, 2025
The type of pharmacare most advocates want to see the policy evolve into is a universal, single-payer model, where governments would foot the majority of prescription drug costs for all Canadians… tens of billions of dollars Canada shells out on prescription medications annually would be better spent within the country’s borders, bolstering domestic production capacity… The gaps exposed by COVID-19 — the procurement chaos, supply chain woes, equipment shortages and expiring oversupply — make some believe pharmacare holds the potential to strengthen Canada’s autonomy and security, too.
Tags: budget, economy, featured, Health, ideology, jurisdiction, participation, pharmaceutical, standard of living
Posted in Health Debates | No Comments »
Health advocates call on Liberals to keep pharmacare promise ahead of budget
Tuesday, September 23rd, 2025
Health Minister Marjorie Michel and Carney’s office declined to commit to signing more pharmacare deals over the summer, and promised only to protect what was in place… The law requires the national drug agency to develop a list of essential drugs for a national formulary and to work on a national bulk-purchasing strategy to bring prices down.
Tags: budget, Health, pharmaceutical, privatization
Posted in Health Debates | No Comments »
Targeted Pharmacare Reforms Could Deliver Access Without a $40 Billion Price Tag
Thursday, September 18th, 2025
With 97 percent of Canadians already having access to some form of drug coverage, a new Conference Report by the C.D. Howe Institute finds that a fiscally responsible approach to universal pharmacare should focus on closing gaps in prescription drug coverage rather than replacing plans with a single-payer system.
Tags: budget, Health, participation, pharmaceutical, privatization
Posted in Health Debates | No Comments »
Recent Comments